| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CNR1 | CNR2 | ENSMLUP00000013631 | ENSMLUP00000017112 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | 0.912 |
| CNR1 | G1PRL6_MYOLU | ENSMLUP00000013631 | ENSMLUP00000013787 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Uncharacterized protein. | 0.532 |
| CNR1 | GNA12 | ENSMLUP00000013631 | ENSMLUP00000022559 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Uncharacterized protein. | 0.532 |
| CNR1 | GNA13 | ENSMLUP00000013631 | ENSMLUP00000000083 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit alpha 13. | 0.519 |
| CNR1 | GNAL | ENSMLUP00000013631 | ENSMLUP00000010143 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein subunit alpha L. | 0.676 |
| CNR1 | GNAS | ENSMLUP00000013631 | ENSMLUP00000007043 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | GNAS complex locus. | 0.676 |
| CNR1 | GPR55 | ENSMLUP00000013631 | ENSMLUP00000003033 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | G protein-coupled receptor 55; Belongs to the G-protein coupled receptor 1 family. | 0.851 |
| CNR1 | NAPEPLD | ENSMLUP00000013631 | ENSMLUP00000000218 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | N-acyl phosphatidylethanolamine phospholipase D. | 0.677 |
| CNR1 | TRPV1 | ENSMLUP00000013631 | ENSMLUP00000014866 | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | Transient receptor potential cation channel subfamily V member 1; Belongs to the transient receptor (TC 1.A.4) family. | 0.618 |
| CNR2 | CNR1 | ENSMLUP00000017112 | ENSMLUP00000013631 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.912 |
| CNR2 | G1PRL6_MYOLU | ENSMLUP00000017112 | ENSMLUP00000013787 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | Uncharacterized protein. | 0.532 |
| CNR2 | GNA12 | ENSMLUP00000017112 | ENSMLUP00000022559 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | Uncharacterized protein. | 0.532 |
| CNR2 | GNA13 | ENSMLUP00000017112 | ENSMLUP00000000083 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein subunit alpha 13. | 0.519 |
| CNR2 | GNAL | ENSMLUP00000017112 | ENSMLUP00000010143 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein subunit alpha L. | 0.676 |
| CNR2 | GNAS | ENSMLUP00000017112 | ENSMLUP00000007043 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | GNAS complex locus. | 0.676 |
| CNR2 | GPR55 | ENSMLUP00000017112 | ENSMLUP00000003033 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | G protein-coupled receptor 55; Belongs to the G-protein coupled receptor 1 family. | 0.822 |
| CNR2 | NAPEPLD | ENSMLUP00000017112 | ENSMLUP00000000218 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | N-acyl phosphatidylethanolamine phospholipase D. | 0.615 |
| CNR2 | TRPV1 | ENSMLUP00000017112 | ENSMLUP00000014866 | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | Transient receptor potential cation channel subfamily V member 1; Belongs to the transient receptor (TC 1.A.4) family. | 0.491 |
| G1PRL6_MYOLU | CNR1 | ENSMLUP00000013787 | ENSMLUP00000013631 | Uncharacterized protein. | Cannabinoid receptor 1; G-protein coupled receptor for cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2- arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effects, acting, among others, on food intake, memory loss, gastrointestinal motility, catalepsy, ambulatory activity, anxiety, chronic pain. Signaling typically involves reduction in cyclic AMP. In the hypothalamus, may have a dual effect on mitochondrial respiration depending upon the agonist dose and possibly upon the cell type. Increases respiration at low doses, while d [...] | 0.532 |
| G1PRL6_MYOLU | CNR2 | ENSMLUP00000013787 | ENSMLUP00000017112 | Uncharacterized protein. | Cannabinoid receptor 2; Belongs to the G-protein coupled receptor 1 family. | 0.532 |